Stock Analysis of Sartorius Stedim Biotech S.A. (0RG8) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code 0RG8
Close 178.80
Change -3.50 / 1.92 %
Volume 331.00
Vol Change -49082.00 / 99.33 %
IndustryMISC
SectorMISC
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Excellent Growth


Fundamental View of Sartorius Stedim Biotech S.A.


Highs/Lows of Sartorius Stedim Biotech S.A.
PeriodOld priceStock ReturnHighLowHigh DateLow Date
One Week174.602.41 % 182.50172.8003-Jul-2629-Jun-26
Two Week164.508.69 % 182.50158.1003-Jul-2623-Jun-26
One Month176.601.25 % 184.30158.1005-Jun-2623-Jun-26
Three Month168.656.02 % 195.70150.0021-Apr-2630-Apr-26
Six Months208.8014.37 % 223.20150.0006-Jan-2630-Apr-26
One year204.0012.35 % 223.20150.0006-Jan-2630-Apr-26
Two year152.2117.47 % 239.30143.6528-Jan-2522-Jul-24
Five year394.6654.70 % 550.00139.4510-Sep-2102-Jul-24
Ten year62.65185.42 % 550.0050.7710-Sep-2117-Oct-17


Technical View of Sartorius Stedim Biotech S.A.






Charts of Sartorius Stedim Biotech S.A.


View All Together in Chart      Inline           Tile



Technicals of Sartorius Stedim Biotech S.A. with Peers
Technical / Stock0RG8-
ADX13.64
CMF-0.0161
MFI71.86
RSI55.96
MACD Abv SignalTrue
Price Above 50 MATrue-
Price Above 200 MAFalse-


About : Sartorius Stedim Biotech S.A.


Address : Zone Industrielle Les Paluds, Aubagne, France, 13781
Tel : 33 4 42 84 56 00
URL : https://www.sartorius.com
Code : 0RG8, Exchange : LSE, Country : UK
Fiscal Year End : December
Employee Count : 10456

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.


Note : All Data Generated at the End of Trading Hours (EOD Data)